Bluestone Jewellery IPO Subscription, GMP, Details & Reviews

Here is the final call for the Bluestone Jewellery IPO launched on 11th August 2025. The issue will be closed for bidding today, on 13th August 2025. The primary aim of the Bluestone Jewellery IPO is to raise ₹1,540.65 crores from the market. Also, the Bluestone Jewellery IPO has received an impressive level of subscription, which indicates that shares will be listed at an impeccable premium. Scroll down to check the Bluestone Jewellery IPO subscription and details. 

Bluestone Jewellery IPO Details 

The price band for the Bluestone Jewellery IPO has been prescribed as Rs 492 to ₹517 per share, and 2,97,99,799 in total shares are to be issued. Let’s segregate the share quota fixed for different categories of investors. 

Bluestone Jewellery IPO Subscription Status

As of now, the Bluestone Jewellery IPO has been subscribed 0.67 times. Of these, 0.79 times are subscribed by retail investors, 0.84 times by non-institutional investors, and 0.24 times by QII (Qualified Institutional Investors).  

The healthy subscription status indicates that investors are expecting higher returns at the time of the Bluestone Jewellery IPO listing on 19th August 2025. Bluestone Jewellery also has a positive outlook behind the fresh issue of 1.59 crore shares to raise around Rs 1,540.65 crores.

Bluestone Jewellery IPO GMP Today

We know that higher subscriptions encourage grey market premiums for the IPOs. Let’s explore the Bluestone Jewellery IPO GMP for 11th August 2025. 

The grey market premium for this IPO is 0.48% or Rs 2.5 per share. It indicates that the estimated listing price per share is Rs 519.5. Numerous factors played a pivotal role in this jump in the Bluestone Jewellery IPO GMP. These include higher subscriptions received, positive market sentiments, and investors’ positive attitude towards IPO. 

About Bluestone Jewellery Ltd.

Bluestone Jewellery and Lifestyle Limited manufactures a variety of jewellery under its brand name, Bluestone, including diamond, gold, platinum, and studded jewellery of its leading brand, BlueStone. Bluestone Jewellery has more than 8,000 unique designs for its customers, which are designed with perfection and care.

• Advanced Manufacturing Capabilities with Vertically Integrated Operations.
• In-house manufacturing drives smooth business operations.
• Leading player in the jewellery brand offering an omni-channel retail experience.
• Pan India presence.

Financial Performance

Assess the financial performance of the company for the past three years to get an idea of the Bluestone Jewellery IPO listing expectations. 

Technical Indicators

A number of technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Bluestone Jewellery IPO.

Bluestone Jewellery IPO Listing Expectations

Bluestone Jewellery Highlights IPO allotment is still pending as the bid will be closed today. However, as per the current GMP or market sentiments, it is appropriate to expect higher listing gains from the share. A flat of 0.48% in Bluestone Jewellery Highlight GMP indicates that the estimated listing price per share will be somewhere around Rs 519.5.

It will provide higher listing gains to investors who applied for this IPO. Also, the financial fundamentals of this business made it the experts’ best recommendations for the long term. 

Bluestone Jewellery IPO Dates

Note: It is to be noted that IPO GMP is volatile based on market sentiment. Hence, one should conduct their research before investing in it.

Also Read : Divi’s Laboratories Q1 Results FY26: Q1 PAT Soars 26.74% to ₹545.00 Crore; Revenue Rises 13.79% YoY

Recent Articles

Finolex Cables Q1 Results FY26: Q1 PAT Falls 33.33% to ₹162.62 Crore; Revenue Up 13.41% YoY

Abbott India Q1 Results FY26: Q1 PAT Rises 11.54% to ₹365.86 Crore; Revenue Up 11.60% YoY

Jyothy Labs Q1 Results FY26: Q1 PAT Falls 4.95% to ₹96.73 Crore; Revenue Up 1.35% YoY

Zydus Lifesciences Q1 Results FY26: Q1 PAT Rises 3.30% to ₹1,466.80 Crore; Revenue Up 5.90% YoY

Bombay Burmah Trading Q1 Results FY26: Q1 PAT Soars 8.28% to ₹240.70 Crore; Revenue Up 8.73% YoY

Alkem Laboratories Q1 Results FY26: Q1 PAT Rises 21.85% to ₹664.26 Crore; Revenue Up 11.19% YoY

Natco Pharma Q1 Results FY26: Q1 PAT Falls 28.09% to ₹480.70 Crore; Revenue Down 2.47% YoY

Hindalco Q1 Results FY26: Q1 PAT Rises 30.00% to ₹4,004.00 Crore; Revenue Up 13.00% YoY